JP7678595B2 - ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法 - Google Patents

ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法 Download PDF

Info

Publication number
JP7678595B2
JP7678595B2 JP2022548109A JP2022548109A JP7678595B2 JP 7678595 B2 JP7678595 B2 JP 7678595B2 JP 2022548109 A JP2022548109 A JP 2022548109A JP 2022548109 A JP2022548109 A JP 2022548109A JP 7678595 B2 JP7678595 B2 JP 7678595B2
Authority
JP
Japan
Prior art keywords
alkyl
equiv
mmol
group
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022548109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512823A (ja
JP2023512823A5 (https=
Inventor
グネディバ，クセニア
ハドスペス，エー．ジェームス
カスタン，ナサニエル
リアン，ルイ
ティー． メインケ，ピーター
ジョン ハギンス，デーヴィッド
ジョン リバートン，ナイジェル
アシュレイ バクスト，レイ
デーヴィッド ジン，ジョン
ウォルター マイヤーズ，ロバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of JP2023512823A publication Critical patent/JP2023512823A/ja
Publication of JP2023512823A5 publication Critical patent/JP2023512823A5/ja
Application granted granted Critical
Publication of JP7678595B2 publication Critical patent/JP7678595B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2022548109A 2020-02-05 2021-02-05 ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法 Active JP7678595B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062970425P 2020-02-05 2020-02-05
US62/970,425 2020-02-05
PCT/US2021/016848 WO2021158936A1 (en) 2020-02-05 2021-02-05 Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss

Publications (3)

Publication Number Publication Date
JP2023512823A JP2023512823A (ja) 2023-03-29
JP2023512823A5 JP2023512823A5 (https=) 2025-03-21
JP7678595B2 true JP7678595B2 (ja) 2025-05-16

Family

ID=77199407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548109A Active JP7678595B2 (ja) 2020-02-05 2021-02-05 ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法

Country Status (8)

Country Link
EP (1) EP4100008B1 (https=)
JP (1) JP7678595B2 (https=)
CN (1) CN115515579B (https=)
AU (1) AU2021215925B2 (https=)
CA (1) CA3170121A1 (https=)
ES (1) ES3025983T3 (https=)
MX (1) MX2022009572A (https=)
WO (1) WO2021158936A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023015156A1 (en) * 2021-08-02 2023-02-09 Hudspeth A James Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation
WO2024211621A1 (en) * 2023-04-04 2024-10-10 Children's Hospital Los Angeles Lats kinase inhibitor to treat retinal degeneration

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009531274A (ja) 2005-12-07 2009-09-03 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド キナーゼ阻害性ピロロピリジン化合物
JP2010514687A (ja) 2006-12-21 2010-05-06 プレキシコン，インコーポレーテッド キナーゼ調節剤としてのピロロ［２，３−ｂ］ピリジン誘導体
JP2020517698A (ja) 2017-04-28 2020-06-18 ノバルティス アーゲー ６−６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
TWI667233B (zh) * 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
GB201602854D0 (en) * 2016-02-18 2016-04-06 Mission Therapeutics Ltd Novel compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009531274A (ja) 2005-12-07 2009-09-03 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド キナーゼ阻害性ピロロピリジン化合物
JP2010514687A (ja) 2006-12-21 2010-05-06 プレキシコン，インコーポレーテッド キナーゼ調節剤としてのピロロ［２，３−ｂ］ピリジン誘導体
JP2020517698A (ja) 2017-04-28 2020-06-18 ノバルティス アーゲー ６−６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用

Also Published As

Publication number Publication date
US20230137893A1 (en) 2023-05-04
WO2021158936A1 (en) 2021-08-12
AU2021215925A1 (en) 2022-09-08
EP4100008B1 (en) 2025-04-02
MX2022009572A (es) 2022-12-13
CA3170121A1 (en) 2021-08-12
EP4100008A4 (en) 2024-02-07
JP2023512823A (ja) 2023-03-29
AU2021215925B2 (en) 2026-04-09
EP4100008A1 (en) 2022-12-14
ES3025983T3 (en) 2025-06-10
CN115515579A (zh) 2022-12-23
CN115515579B (zh) 2025-09-30

Similar Documents

Publication Publication Date Title
CN107072985B (zh) 治疗性抑制化合物
TW202144345A (zh) Ｋｒａｓ突變蛋白抑制劑
CN113454081B (zh) 咪唑并吡啶基化合物及其用于治疗增生性疾病的用途
TW202122388A (zh) Ｒｉｐ１抑制性化合物和用於製備和使用其之方法
CA2972148A1 (en) Benzazepine dicarboxamide compounds
CA2672926A1 (en) Bicyclic heteroaromatic compounds
JPWO2002062775A1 (ja) ２−アシルアミノチアゾール誘導体又はその塩
JP2007502820A (ja) Ｎ−置換ピラゾリル−アミジル−ベンズイミダゾリルｃ−Ｋｉｔ阻害剤
TW200922583A (en) Certain chemical entities, compositions, and methods
WO2014151630A2 (en) Compounds and compositions for the treatment of parasitic diseases
CA3108773A1 (en) 2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases
CA2688326A1 (en) Tetrahydroisoquinolin-1-one derivative or salt thereof
JP7678595B2 (ja) ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法
CN107163044A (zh) 一类具有蛋白酶修饰活性的萘乙二酮化合物及其衍生物
CN110156782B (zh) 作为pi3k/mtor抑制剂的吡啶基取代的稠合喹啉化合物
KR20230067669A (ko) 2-아미노-3-카르보닐 이미다조피리딘 및 피라졸로피리딘 화합물
TWI673049B (zh) 治療及／或預防纖維性疾病之胺基萘醌化合物
US20240343726A1 (en) Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation
US12617785B2 (en) Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss
JP2021535924A (ja) 新規なチアゾール誘導体及びその薬学的に許容される塩
WO2023225601A2 (en) Ripk2 and nod inhibitors
WO2025180442A1 (zh) Hdac抑制剂及其在医药上的应用
HK40083035B (zh) Parp7抑制剂及其用途
WO2024249488A2 (en) Inhibitors of dyrk1a
TW202434599A (zh) 造血前驅細胞激酶1之吡啶酮及嘧啶酮抑制劑

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241217

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241219

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20250311

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250401

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250424

R150 Certificate of patent or registration of utility model

Ref document number: 7678595

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150